Interesting. I just checked myself and it appears as though they will require the general public to register with the site to be able to have access to the abstracts. That is how I read it when looking at the page. Anyway I signed up myself and now have access. It doesn't seem to be connected to being registered with the conference as an attendee. Nothing to be gleaned from it thus far which is not surprising since everything is still under embargo. Hopefully tomorrow brings some good and clearer news for us.
Lilly live webcast of EXPEDITION 3: A phase 3 Trial of Solanezumab in Mild Dementia due to Alzheimer’s Disease at 6:15 PST. You can register for that and listen on as well. Poor Dr. Aisen will have to discuss his disappointment with the study after pushing so hard to keep it alive. Maybe AVXL will keep his spirits up.
News 
Market Data 
Discover 
